Elsewhere in the market, the S&P 500 Index has stumbled -1.30% in last trading session, with the Dow Jones Industrial also saw a negative session on the day with -0.94%.Īn analysis of the ViewRay Inc. (RMD) traded -2.74% in the last session and was positioned 52.25% up on its price 12 months ago. stock has performed in comparison to its peers in the industry, here’s what we find: VRAY’s stock is -5.44% on the day and 93.55% in the past 12 months, while ResMed Inc. Turning out attention to how the ViewRay Inc. Investors will no doubt be excited to see the share price fall to $8.00, which is the median consensus price, and at that level VRAY would be -21.21% from current price. Based on this estimate, we see that current price is roughly -6.06% off the estimated low and -36.36% off the forecast high. Considering analysts have assigned the stock a price target range of $7.00-$9.00 as the low and high respectively, we find the trailing 12-month average consensus price target to be $8.00. (NASDAQ:VRAY)’s beta value is holding at 0.93, while the average true range (ATR) indicator is currently reading 0.36. The indicator jumps to 4.99% when calculated based on the past 30 days. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 50.48, with weekly volatility standing at 6.33%. The overview shows that VRAY’s price is at present 0.20% off the SMA20 and 5.72% from the SMA50. In general, analysts have rated the stock Overweight, a scenario likely to bolster investors out for an opportunity to add to their holdings of the company’s shares. (VRAY) stock as Underweight, with 0 recommending Sell. 0 analyst(s) have tagged the ViewRay Inc. Specifically, 7 analysts have assigned VRAY a recommendation rating as follows: 2 rate it as a Hold 5 advise Buy while 0 analyst(s) assign an Overweight rating. Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Buy, while an average of long term indicators are currently assigning the stock as 100% Buy. On the technical perspective front, indicators give VRAY a short term outlook of 50% Buy on average. Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. Per this projection, the revenue is forecast to grow 20.60% above that which the company brought in 2021. Staying with the analyst view, there is a consensus estimate of $68.79 million for the company’s annual revenue in 2021. The average estimate suggests sales growth for the quarter will likely rise by 62.60% when compared to those recorded in the same quarter in the last financial year. On average, analysts have forecast the company’s revenue for the quarter will hit $16.4 million, with the likely lows of $15.2 million and highs of $20.5 million. In this case, analysts estimate an annual EPS growth of 4.10% for the year and 8.60% for the next year. Analysts tracking VRAY have forecast the quarterly EPS to shrink by -0.17 per share this quarter, while the same analysts predict the annual EPS to hit -$0.7 for the year 2021 and up to -$0. ViewRay Inc., which has a market valuation of $1.12 billion, is expected to release its quarterly earnings report – Nov 08, 2021.
VRAY STOCK PRICE FOR FREE
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.Ĭlick here for full details and to join for free For stock market investors that means buying up cheap small cap stocks like these with huge upside potential. He buys up valuable assets when they are very cheap. 3 Tiny Stocks Primed to Explode The world's greatest investor - Warren Buffett - has a simple formula for making big money in the markets.